NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The investigation concerns whether Nutex and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

Intel Corp (NASDAQ:INTC, ETR:INL) is in discussions with several large investors to raise fresh capital through a discounted equity infusion, according to a CNBC report citing people familiar with the matter. The talks follow a $2 billion investment from Japan's SoftBank, which purchased shares at $23 each, slightly below the company's recent closing price of $23.66.

Fifth Third expanded the capabilities of its commercial payments business by acquiring DTS Connex, a provider of cash management software solutions for multi-location businesses like retailers, restaurants and healthcare providers.

DAVE's second-quarter adjusted net income soared 233% with elevated guidance, but rising delinquencies test its margin strength.

KO's bold global marketing, from "Share a Coke" to local campaigns, is fueling revenue growth despite softer volumes.

Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.

The impulsive reaction to Target's long-overdue CEO change is — what took so long?

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Jonathan C. Javitt - Co-Founder, Chief Scientist Officer, Chairman & Interim CEO Matthew Patrick Duffy - Chief Business Officer & Co-CEO of Hope Therapeutics Michael S.

Tesla CEO Elon Musk said the company's new six-seat Model Y variant, launched in China this week, might never enter production in the United States, citing the rise of self-driving vehicles.

TTD posts Q2 revenue growth above guidance, driven by CTV strength, AI-powered Kokai adoption and expanding media partnerships.

DXCM grows on type 2 access, Stelo adoption, and new sensor launches, but faces margin pressures, competition and leadership transition.

GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.

SBUX shares have lost 19% in six months as U.S. sales falter, margins shrink and its turnaround faces execution risks.

Unlike many of its rivals, Alaska Airlines is giving members of its new loyalty program a choice on how they earn rewards points.

U.S. equities were mostly in the red at midday, dragged for a second session by tech stocks, as well as a mixed bag of earnings news. The Nasdaq dropped 1%, the S&P 500 was down as well, while the Dow Jones Industrial Average was little changed.

If the original Silk Road moved silk and spices, the 2025 version is trading in silicon. At the center sits NVIDIA Corp NVDA, the $4 trillion chip colossus, threading its GPUs through the geopolitical maze of China's firewalls and Saudi Arabia's gilded data palaces.

Key Points in This Article: This isn't Warren Buffett's first foray into the homebuilder market.

Sony will raise prices of its PlayStation 5 consoles in the United States by around $50 from Thursday, as the Japanese conglomerate navigates a slow recovery in the videogame market while U.S. tariffs threaten to raise costs.

Auna S.A. (NYSE:AUNA ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Ana Maria Mora - Head of Investor Relations Gisele Remy Ferrero - CFO & Executive VP Jesús Antonio Zamora Leon - President, CEO & Executive Chairman of the Board Conference Call Participants Artur do Amaral Alves - Morgan Stanley, Research Division Leandro Bastos - Citigroup Inc., Research Division Operator Good morning, and welcome to Auna's Second Quarter 2025 Earnings Conference Call. My name is Ellie, and I will be your operator for today's call.

KEYS beats Q3 earnings and revenue estimates, fueled by AI data-center demand plus strength in aerospace, defense and government markets.